Navigator Medicines

Navigator Medicines is a biotechnology company dedicated to developing biologics for targeted immune modulation and restoration. Established in 2024 as a subsidiary of Sera Medicines, the company focuses on developing novel therapies for patients with complex, heterogeneous autoimmune diseases.